Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pain, Intractable × Fentanyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Pain 3 Burns 2 Breakthrough Pain 2 Anemia, Sickle Cell 2 Agnosia 2 Pain, Postoperative 1 Pain, Intractable 1 Lung Neoplasms 1 Intrathecal Dexmedetomidine 1 Dyspnea, Paroxysmal 1 Colonic Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1

Interventions

ziconotide 1 resiniferatoxin 1 Midazolam 1 Fentanyl 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00216658 2011-01-24

Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -

Janssen Pharmaceutical K.K.

Phase 2 Completed

Cancer Pain, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡